wellrank.ai
Casa Pharma Rx logo

Casa Pharma Rx

First cited by AI Jun 12, 2026

Surfaced organically in AI answers about compounded glp-1s. Not yet profiled.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning Casa Pharma Rx, through Jun 13, 2026.

8.3%

Avg position when mentioned: 8.0

By engine

Where Casa Pharma Rx is strong, and where it is invisible.

  • Perplexity
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 2 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Casa Pharma Rx

PerplexityJun 13, 2026, 11:14 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

The providers in your results that explicitly say they use licensed U.S. pharmacies are OrderlyMeds and Empower Pharmacy.[1][2] OrderlyMeds says it “exclusively works with pharmacies based in the United States,” and that medication is compounded at “U.S. based licensed pharmacies.”[1] Empower Pharmacy says it offers compounded GLP-1 injections from its 503A PCAB-accredited compounding pharmacy and that it is “licensed to ship nationwide.”[2] A few other providers in your results say they use regulated or licensed compounding pharmacies, but the wording is less specific about U.S. licensing: Fridays says its compounded GLP-1 medications are sourced from “rigorously regulated pharmacies,” but the result does not name the pharmacies or explicitly say “licensed U.S. pharmacies” on that page.[8] Henry Meds is described in the search results as using 503A or 503B compounding pharmacies, including named partners such as Belmar, Strive, Epiq Scripts, and Casa Pharma Rx, but the result does not clearly state in the excerpt that all are licensed U.S. pharmacies.[6] If you want, I can turn this into a short buyer’s comparison of these providers based on pharmacy licensing, transparency, and GLP-1 availability.

Mentioned in position 8 of 8

Read full answer with sources →
PerplexityJun 12, 2026, 10:26 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

Based on the provided search results, the following compounded GLP-1 providers explicitly state that they use licensed US pharmacies (specifically citing 503A or 503B facilities based in the United States): OrderlyMeds Explicitly states they work "exclusively with pharmacies based in the United States." Lists specific US partners: SmartPharmaRx, Casa, and PerfectRx/PerfectionRx. Describes itself as a "100% online platform that connects patients to licensed healthcare professionals in all 50 states." Empower Pharmacy States their medications are made at a "503A PCAB-Accredited compounding pharmacy" (a US standard). Confirms they are licensed to "ship nationwide, including Puerto Rico," indicating a US-based operation. Henry Meds (and its partner Adonis Health Inc.) Described as "upfront" about using both 503A and 503B compounding pharmacies. Cites partner pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx (all US-based entities). Fridays Weight Loss Program (joinfridays.com) States they "deliver from 503A and 503B certified compounding pharmacies." While they do not name all partners on marketing pages, they reference Beaker Pharmacy as a fulfillment partner. The FDA clarification mentioned in the text notes that compounded semaglutide must legally come from 503A pharmacies (US standard), which Fridays claims to use. Schaffner Pharmacy Explicitly states their products are made by "FDA certified 503B compounding pharmacies," which are US-regulated facilities. Important Regulatory Context (from results): FDA Shortage Status: As of May 2025, the FDA shortages for semaglutide and tirzepatide injections have been resolved. Consequently, pharmacies are generally no longer allowed to regularly compound "essentially copies" of commercially available GLP-1s. Current Availability: Compounded versions are now largely phased out and should only be used for specific medical needs that commercial products cannot meet (e.g., non-standard doses or removing allergens). 503A vs. 503B: 503A pharmacies are traditional compounding pharmacies licensed by state boards for individual patients, while 503B facilities are outsourcing facilities regulated by the FDA. Both are US-licensed entities. Summary: The providers most clearly identified as using licensed US pharmacies are OrderlyMeds, Empower Pharmacy, Henry Meds, Fridays, and Schaffner Pharmacy. OrderlyMeds is the most explicit about its exclusive use of US-based partners.

Mentioned in position 11 of 14

Read full answer with sources →

Public AI visibility history

Daily rank of Casa Pharma Rx on our buyer intent questions, per category. A dash means the engines did not cite Casa Pharma Rx at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Compounded GLP-1s#78#35

TL;DR

Casa Pharma Rx is a compounding pharmacy operating in the telehealth and direct-to-consumer space, known for offering compounded GLP-1 medications such as semaglutide. According to WellRank's latest index, it ranks 14th in the Compounded GLP-1s category with 8% AI answer visibility, placing it among a competitive mid-tier of specialty compounders and telehealth platforms that AI engines surface when consumers search for compounded weight-loss therapies.

Company Overview

Casa Pharma Rx is a compounding pharmacy that provides prescription compounded medications, with a notable presence in the GLP-1 weight management category. Its founding date and headquarters are not publicly disclosed in widely available sources. The business model appears to center on dispensing compounded formulations, likely through a direct-to-patient or prescriber-partnered channel, though the precise operational structure is not publicly confirmed.

Product Features

  • Compounded semaglutide formulations
  • Compounded GLP-1 receptor agonist products for weight management
  • Prescription-required dispensing process
  • Direct-to-patient or telehealth-partnered fulfillment
  • Specialty compounding pharmacy services

Target Market

Casa Pharma Rx appears to serve adult patients pursuing GLP-1-based weight loss or metabolic health treatment who are seeking compounded alternatives to branded medications. Its geographic reach is not publicly confirmed, though U.S.-based compounding pharmacies operating in this space typically serve patients nationally where permitted by state law.

Buyer Personas

  • A cost-conscious adult seeking a more affordable compounded alternative to brand-name semaglutide injections for weight management.
  • A telehealth patient whose online provider partners with specialty compounders to fulfill GLP-1 prescriptions.
  • A returning weight-loss program participant looking to maintain access to compounded semaglutide amid supply or regulatory shifts.
  • A healthcare-informed consumer who has researched compounding pharmacy options and encountered Casa Pharma Rx through AI-generated answer results.

Funding & Performance

Funding stage, investment history, and company scale are not publicly disclosed. Casa Pharma Rx does not appear to have announced any funding rounds or valuations in widely available sources.

Recent Developments

Casa Pharma Rx has surfaced organically in AI-generated answers related to compounded GLP-1s, a category under significant regulatory scrutiny. The FDA has taken steps to address the status of compounded semaglutide, as covered in outlets like Scientific American, which affects all compounders in this space. The broader context of compounded GLP-1 availability and compliance is an evolving area that shapes how pharmacies like Casa Pharma Rx are positioned in the market.

Competitive Landscape

Based on WellRank co-mention data, Casa Pharma Rx is most frequently cited alongside OrderlyMeds, Henry Meds, Fridays, Epiq Scripts, Empower Pharmacy, Strive Pharmacy, and SmartPharmaRx in AI-generated answers about compounded GLP-1s. It competes in a fragmented market where large 503B outsourcing facilities like Empower Pharmacy carry significant name recognition, while platforms like Fridays and OrderlyMeds combine telehealth access with compounding fulfillment. At 8% AI visibility and rank 14, Casa Pharma Rx holds a presence but trails the more prominently cited brands in this category.

Casa Pharma Rx vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Casa Pharma Rx logo
Casa Pharma RxThis brand
#35
8.3%
Empower Pharmacy logo
Empower Pharmacy

2 shared answers

#2
41.7%
Epiq Scripts logo
Epiq Scripts

2 shared answers

#34
8.3%
Fridays logo
Fridays

2 shared answers

#36
8.3%
Henry Meds logo
Henry Meds

2 shared answers

#4
33.3%

Email me when overtakes Casa Pharma Rx

One email the day the ranks flip. Nothing else.

User Sentiment

AI engines treat Casa Pharma Rx in a purely neutral tone across both mentions captured in WellRank's corpus, with zero positive or cautious signals recorded. This suggests it is referenced as a factual option rather than evaluated or recommended, which is consistent with a brand that has limited public review history and has not yet accumulated a strong editorial or consumer-generated reputation. Sources that engines cite in answers mentioning it include general GLP-1 policy and comparison resources such as GoodRx's compounded GLP-1 coverage and the American Med Spa Association FAQ, indicating it appears in informational rather than endorsement contexts.

Pricing

Pricing for Casa Pharma Rx's compounded medications is not publicly published in any widely available source. As with most compounding pharmacies in this space, pricing likely varies based on formulation, dosage, and prescription requirements.

Sources cited around Casa Pharma Rx

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Casa Pharma Rx weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Casa Pharma Rx? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.